Cargando…
Exploiting Herpes Simplex Virus Entry for Novel Therapeutics
Herpes Simplex virus (HSV) is associated with a variety of diseases such as genital herpes and numerous ocular diseases. At the global level, high prevalence of individuals who are seropositive for HSV, combined with its inconspicuous infection, remains a cause for major concern. At the molecular le...
Autores principales: | Hadigal, Satvik, Shukla, Deepak |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3717716/ https://www.ncbi.nlm.nih.gov/pubmed/23752649 http://dx.doi.org/10.3390/v5061447 |
Ejemplares similares
-
Zinc oxide tetrapods inhibit herpes simplex virus infection of cultured corneas
por: Duggal, Neil, et al.
Publicado: (2017) -
Herpes Simplex Virus Cell Entry Mechanisms: An Update
por: Madavaraju, Krishnaraju, et al.
Publicado: (2021) -
Heparanase is a Host Enzyme Required for Herpes Simplex Virus-1 Release from Cells
por: Hadigal, Satvik R., et al.
Publicado: (2015) -
A novel role for phagocytosis-like uptake in herpes simplex virus entry
por: Clement, Christian, et al.
Publicado: (2006) -
Phosphoinositide 3 kinase signalling may affect multiple steps during herpes simplex virus type-1 entry
por: Tiwari, Vaibhav, et al.
Publicado: (2010)